142 related articles for article (PubMed ID: 8681020)
1. [Malignancy in autoimmune diseases].
Sugai S
Nihon Rinsho Meneki Gakkai Kaishi; 1996 Feb; 19(1):1-14. PubMed ID: 8681020
[TBL] [Abstract][Full Text] [Related]
2. [Lymphoproliferative disorders in patients with Sjögren's syndrome--Vg gene rearrangement and expression of bcl-2 protein].
Sugai S; Takeshita S; Ogawa Y; Masaki Y; Doumiki T; Takeuchi Y
Nihon Rinsho; 1995 Oct; 53(10):2580-6. PubMed ID: 8531377
[TBL] [Abstract][Full Text] [Related]
3. Rearrangement of the rheumatoid factor-related germline gene Vg and bcl-2 expression in lymphoproliferative disorders in patients with Sjögren's syndrome.
Sugai S; Saito I; Masaki Y; Takeshita S; Shimizu S; Tachibana J; Miyasaka N
Clin Immunol Immunopathol; 1994 Aug; 72(2):181-6. PubMed ID: 8050191
[TBL] [Abstract][Full Text] [Related]
4. Malignant lymphomas in patients with autoimmune diseases: a report of 6 cases and a review of the Japanese literature.
Sugai S; Tachibana J; Sawada M; Shimizu S; Hirose Y; Takiguchi T; Konda S
Jpn J Med; 1987 Aug; 26(3):339-47. PubMed ID: 3320428
[TBL] [Abstract][Full Text] [Related]
5. TP53 gene mutation, an unfavorable prognostic factor for malignant lymphomas in autoimmune diseases.
Hoshida Y; Hongyo T; Xu JX; Sasaki T; Tomita Y; Nomura T; Aozasa K
Oncology; 2005; 69(2):175-83. PubMed ID: 16131817
[TBL] [Abstract][Full Text] [Related]
6. Association of systemic and thyroid autoimmune diseases.
Biró E; Szekanecz Z; Czirják L; Dankó K; Kiss E; Szabó NA; Szucs G; Zeher M; Bodolay E; Szegedi G; Bakó G
Clin Rheumatol; 2006 Mar; 25(2):240-5. PubMed ID: 16247581
[TBL] [Abstract][Full Text] [Related]
7. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
8. Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice.
Toda I; Wickham LA; Sullivan DA
Clin Immunol Immunopathol; 1998 Jan; 86(1):59-71. PubMed ID: 9434797
[TBL] [Abstract][Full Text] [Related]
9. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative disorders in Japanese patients with Sjögren's syndrome.
Sugai S; Shimizu S; Konda S
Scand J Rheumatol Suppl; 1986; 61():118-22. PubMed ID: 3473620
[TBL] [Abstract][Full Text] [Related]
11. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR
Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases.
Suvajdzic N; Djurdjevic P; Todorovic M; Perunicic M; Stojanović R; Novkovic A; Mihaljevic B
Med Oncol; 2012 Sep; 29(3):2207-11. PubMed ID: 21755372
[TBL] [Abstract][Full Text] [Related]
14. Oncogene expression in autoimmune mice.
Mountz JD; Mushinski JF; Mark GE; Steinberg AD
J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
[TBL] [Abstract][Full Text] [Related]
15. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
16. Analysis of p53 and Bak gene mutations in lymphoproliferative disorders developing in rheumatoid arthritis.
Xu JX; Hoshida Y; Hongyo T; Sasaki T; Miyazato H; Tomita Y; Aozasa K
J Cancer Res Clin Oncol; 2007 Feb; 133(2):125-33. PubMed ID: 16988840
[TBL] [Abstract][Full Text] [Related]
17. [Sjögren's syndrome as a lymphoaggressive disorder; bcl-2 expression in lymphocytes infiltrated in salivary glands].
Takeshita S; Sugai S
Nihon Rinsho; 1995 Oct; 53(10):2440-5. PubMed ID: 8531352
[TBL] [Abstract][Full Text] [Related]
18. Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study.
Chen HH; Chao WC; Liao TL; Lin CH; Chen DY
PLoS One; 2018; 13(7):e0201340. PubMed ID: 30048527
[TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection.
Hoshida Y; Tomita Y; Zhiming D; Yamauchi A; Nakatsuka S; Kurasono Y; Arima Y; Tsudo M; Shintaku M; Aozasa K
Int J Cancer; 2004 Jan; 108(3):443-9. PubMed ID: 14648712
[TBL] [Abstract][Full Text] [Related]
20. Atypical lymphoplasmacytic and immunoblastic proliferation of autoimmune disease : clinicopathologic and immunohistochemical study of 9 cases.
Kojima M; Nakamura N; Tsukamoto N; Itoh H; Matsuda H; Kobayashi S; Ueki K; Irisawa H; Murayama K; Igarashi T; Masawa N; Nakamura S
J Clin Exp Hematop; 2010; 50(2):113-9. PubMed ID: 21123969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
